Similar articles for PMID: 19759108

Year	Number of Results
2001	1
2002	4
2003	1
2004	4
2006	2
2007	3
2008	4
2009	5
2010	1
2011	5
2012	4
2013	4
2014	6
2015	11
2016	10
2017	6
2018	7
2019	13
2020	7
2021	4
2023	1
2024	0

1

2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.

Pillarsetty N, Punzalan B, Larson SM. Pillarsetty N, et al. J Nucl Med. 2009 Oct;50(10):1709-14. doi: 10.2967/jnumed.109.064212. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759108 Free PMC article.

2

Validation of R-2-[¹⁸F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer.

Zhang Z, Liu S, Ma H, Nie D, Wen F, Zhao J, Sun A, Yuan G, Su S, Xiang X, Hu P, Tang G. Zhang Z, et al. Mol Imaging Biol. 2019 Dec;21(6):1127-1137. doi: 10.1007/s11307-019-01346-1. Mol Imaging Biol. 2019. PMID: 30847820

3

18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate.

Ponde DE, Dence CS, Oyama N, Kim J, Tai YC, Laforest R, Siegel BA, Welch MJ. Ponde DE, et al. J Nucl Med. 2007 Mar;48(3):420-8. J Nucl Med. 2007. PMID: 17332620 Free article.

4

Propionic Acid-Based PET Imaging of Prostate Cancer.

Zhang Z, Liu S, Ma H, Xiang X, Nie D, Hu P, Tang G. Zhang Z, et al. Mol Imaging Biol. 2021 Dec;23(6):836-845. doi: 10.1007/s11307-021-01608-x. Epub 2021 Apr 19. Mol Imaging Biol. 2021. PMID: 33876336

5

In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.

Zhang L, Yao X, Cao J, Hong H, Zhang A, Zhao R, Zhang Y, Zha Z, Liu Y, Qiao J, Zhu L, Kung HF. Zhang L, et al. Mol Pharm. 2019 Mar 4;16(3):1156-1166. doi: 10.1021/acs.molpharmaceut.8b01131. Epub 2019 Feb 20. Mol Pharm. 2019. PMID: 30676751

6

Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.

Harada N, Kimura H, Onoe S, Watanabe H, Matsuoka D, Arimitsu K, Ono M, Saji H. Harada N, et al. J Nucl Med. 2016 Dec;57(12):1978-1984. doi: 10.2967/jnumed.116.175810. Epub 2016 Jul 14. J Nucl Med. 2016. PMID: 27417647 Free article.

7

Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.

Kukuk D, Reischl G, Raguin O, Wiehr S, Judenhofer MS, Calaminus C, Honndorf VS, Quintanilla-Martinez L, Schönberger T, Duchamp O, Machulla HJ, Pichler BJ. Kukuk D, et al. J Nucl Med. 2011 Oct;52(10):1654-63. doi: 10.2967/jnumed.110.086702. Epub 2011 Aug 22. J Nucl Med. 2011. PMID: 21859811 Free article.

8

Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer.

Kwan KH, Burvenich IJG, Centenera MM, Goh YW, Rigopoulos A, Dehairs J, Swinnen JV, Raj GV, Hoy AJ, Butler LM, Scott AM, White JM, Ackermann U. Kwan KH, et al. Nucl Med Biol. 2021 Feb;93:37-45. doi: 10.1016/j.nucmedbio.2020.11.007. Epub 2020 Nov 28. Nucl Med Biol. 2021. PMID: 33310350 Free PMC article.

9

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

10

Antilipolytic drug boosts glucose metabolism in prostate cancer.

Andersen KF, Divilov V, Koziorowski J, Pillarsetty N, Lewis JS. Andersen KF, et al. Nucl Med Biol. 2013 May;40(4):524-8. doi: 10.1016/j.nucmedbio.2013.01.008. Epub 2013 Feb 28. Nucl Med Biol. 2013. PMID: 23454248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year